RNAi Therapeutics

Pages

▼
Showing posts with label AVI-6002. Show all posts
Showing posts with label AVI-6002. Show all posts
Wednesday, November 30, 2011

SNALP Delivery Keeps On Giving: Tekmira Receives OK for Ebola Clinical Studies

›
On Monday, Tekmira announced that it has received the Green Light from the FDA to go ahead with clinical studies of its SNALP-enabled biode...
12 comments:
Monday, August 23, 2010

A comparison of Tekmira’s and AVI Biopharma’s Candidates for the Treatment of Ebola Virus

›
I was quite amused today, while driving a car on Borneo, the local radio report the headline ‘US scientists said that they are ready to star...
4 comments:
›
Home
View web version
Powered by Blogger.